Tom Howard, a cannabis industry lawyer, breaks down the recent order from Acting Attorney General Todd Blanche concerning marijuana rescheduling. He discusses the complex new regulations and laws that are creating Schedule 3 Marijuana, highlighting the significant legal news and implications for cannabis legalization usa. This analysis clarifies how the order applies to A9-THC derived from the marijuana plant, but not synthetically derived THC, which remains Schedule 1.

He explains the order’s “two-lane” approach: Schedule III for FDA-approved marijuana drug products and marijuana handled under qualifying state medical marijuana licenses, while adult-use and other unlicensed bulk marijuana remain Schedule I to satisfy Single Convention obligations. Howard highlights extensive treaty-driven controls (DEA registration, prescriptions, recordkeeping, security, supply limits, and a government purchase/resale mechanism), notes references to 280E and possible Treasury considerations, and predicts imminent legal challenges by Smart Approaches to Marijuana and Torridon Law amid ongoing broader rescheduling proceedings.

00:00 Schedule Three Shock
01:14 Treaty Based Rescheduling
05:22 Why Medical Only
09:09 Skipping The Hearing
10:17 Science And HHS Findings
13:19 Two Lane Schedule Split
16:29 DEA Rules And Compliance
19:08 Government Purchase Scheme
21:08 Regulatory Analysis Pushback
22:50 New Definitions And Timeline
24:54 Naturally Derived THC Twist
25:37 Lawsuits And What Comes Next
30:13 Wrap Up And Subscribe